Skip to main content
Satellos Bioscience Inc. (TSX:MSCL)
Canada flag Canada · Delayed Price · Currency is CAD
16.20
-0.76 (-4.48%)
Mar 6, 2026, 3:59 PM EST

Satellos Bioscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Cost of Revenue
16.6813.626.682.761.60.7
Upgrade
Gross Profit
-16.68-13.62-6.68-2.76-1.6-0.7
Upgrade
Selling, General & Admin
7.375.75.033.471.310.71
Upgrade
Research & Development
-----0.03-0.21
Upgrade
Amortization of Goodwill & Intangibles
----0.13-
Upgrade
Operating Expenses
7.375.75.033.472.170.56
Upgrade
Operating Income
-24.06-19.33-11.71-6.23-3.77-1.26
Upgrade
Interest Expense
---0.13--0.04-0
Upgrade
Interest & Investment Income
1.270.951.010.050.010
Upgrade
Currency Exchange Gain (Loss)
1.271.6-0.88-0.050-0
Upgrade
Other Non Operating Income (Expenses)
0-000-8.460.03
Upgrade
EBT Excluding Unusual Items
-21.51-16.78-11.71-6.23-12.25-1.24
Upgrade
Gain (Loss) on Sale of Investments
-0.03-0.03----
Upgrade
Asset Writedown
0.09-2.72--2.13--
Upgrade
Other Unusual Items
---0.32---
Upgrade
Pretax Income
-21.45-19.53-12.03-8.36-12.25-1.24
Upgrade
Income Tax Expense
0.11--0--
Upgrade
Net Income
-21.57-19.53-12.03-8.37-12.25-1.24
Upgrade
Net Income to Common
-21.57-19.53-12.03-8.37-12.25-1.24
Upgrade
Shares Outstanding (Basic)
13107321
Upgrade
Shares Outstanding (Diluted)
13107321
Upgrade
Shares Change (YoY)
40.78%32.84%142.17%48.20%35.60%62.72%
Upgrade
EPS (Basic)
-1.63-2.04-1.67-2.81-6.11-0.84
Upgrade
EPS (Diluted)
-1.63-2.04-1.67-2.81-6.11-0.84
Upgrade
Free Cash Flow
-21.23-17.36-8.79-4.17-3.98-1.3
Upgrade
Free Cash Flow Per Share
-1.60-1.81-1.22-1.40-1.99-0.88
Upgrade
EBITDA
-24.04-19.31-11.7-5.98-3.64-1.26
Upgrade
D&A For EBITDA
0.010.010.010.250.130
Upgrade
EBIT
-24.06-19.33-11.71-6.23-3.77-1.26
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.